Overview
No overview information available.
Background
No background information available.
Indication
用于治疗缺钙及缺锌性疾病:如佝偻病、骨质疏松及缺锌引起的儿童生长和智力发育迟缓以及食欲不振等症。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Calcium and Zinc Gluconates Oral Solution | 国药准字H20059419 | 化学药品 | 口服溶液剂 | 9/1/2020 | |
Calcium and Zinc Gluconates Oral Solution | 国药准字H20193310 | 化学药品 | 口服溶液剂 | 11/4/2019 | |
Calcium and Zinc Gluconates Oral Solution | 国药准字H20065022 | 化学药品 | 口服溶液剂 | 2/5/2021 | |
Calcium and Zinc Gluconates Oral Solution | 国药准字H20094212 | 化学药品 | 口服溶液剂 | 11/19/2019 | |
Calcium and Zinc Gluconates Oral Solution | 国药准字H20013241 | 化学药品 | 口服溶液剂 | 3/24/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |